- Home
- LIPO vs VRPX Comparison
LIPO vs VRPX Comparison
Compare LIPO & VRPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIPO
- VRPX
- Stock Information
- Founded
- LIPO 2005
- VRPX 2016
- Country
- LIPO United States
- VRPX United States
- Employees
- LIPO N/A
- VRPX N/A
- Industry
- LIPO Biotechnology: Pharmaceutical Preparations
- VRPX Medicinal Chemicals and Botanical Products
- Sector
- LIPO Health Care
- VRPX Health Care
- Exchange
- LIPO Nasdaq
- VRPX Nasdaq
- Market Cap
- LIPO 3.5M
- VRPX 3.7M
- IPO Year
- LIPO 2022
- VRPX 2021
- Fundamental
- Price
- LIPO $2.66
- VRPX $0.31
- Analyst Decision
- LIPO Strong Buy
- VRPX Hold
- Analyst Count
- LIPO 1
- VRPX 1
- Target Price
- LIPO $16.00
- VRPX N/A
- AVG Volume (30 Days)
- LIPO 169.2K
- VRPX 10.4M
- Earning Date
- LIPO 11-14-2024
- VRPX 11-14-2024
- Dividend Yield
- LIPO N/A
- VRPX N/A
- EPS Growth
- LIPO N/A
- VRPX N/A
- EPS
- LIPO N/A
- VRPX N/A
- Revenue
- LIPO $483,533.00
- VRPX N/A
- Revenue This Year
- LIPO N/A
- VRPX N/A
- Revenue Next Year
- LIPO N/A
- VRPX N/A
- P/E Ratio
- LIPO N/A
- VRPX N/A
- Revenue Growth
- LIPO 0.78
- VRPX N/A
- 52 Week Low
- LIPO $2.21
- VRPX $0.29
- 52 Week High
- LIPO $12.00
- VRPX $5.48
- Technical
- Relative Strength Index (RSI)
- LIPO 45.43
- VRPX 32.89
- Support Level
- LIPO $2.53
- VRPX $0.29
- Resistance Level
- LIPO $2.79
- VRPX $0.48
- Average True Range (ATR)
- LIPO 0.29
- VRPX 0.05
- MACD
- LIPO -0.01
- VRPX -0.00
- Stochastic Oscillator
- LIPO 12.62
- VRPX 13.21
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
About VRPX Virpax Pharmaceuticals Inc.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.